Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up Following Better-Than-Expected Earnings

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $11.29, but opened at $11.91. Aveanna Healthcare shares last traded at $11.8650, with a volume of 819,480 shares changing hands.

The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Strong Q2 results: Second-quarter revenue rose 13.7% year over year to $670.5 million, surpassing the $638.6 million analyst estimate. Adjusted earnings of $0.22 per share also exceeded consensus expectations, while net income increased to $40.3 million from $27.0 million a year earlier. Aveanna Healthcare second-quarter results and revised guidance
• Positive Sentiment: Guidance raised: Aveanna increased 2026 revenue guidance to more than $2.68 billion, up from $2.63 billion to $2.65 billion, and lifted adjusted EBITDA guidance to more than $365 million from $338 million to $342 million. The upgraded outlook signals stronger expected operating momentum. Aveanna hits 52-week high after Q2 beat and guidance hike
• Positive Sentiment: Analyst becomes more bullish: BMO Capital Markets raised its price target from $10 to $14 and upgraded the stock to “outperform,” implying additional upside from the referenced $11.29 level. Benzinga analyst price-target report
• Neutral Sentiment: Business momentum remains concentrated: Private Duty Services generate approximately 83% of revenue. Analysts highlighted strong growth and attractive forward valuation, but investors will be watching whether the company can sustain that growth across its broader home-care platform.
• Negative Sentiment: Margin pressure is a risk: Gross margins declined across all business segments in the quarter. Continued revenue growth has offset that pressure so far, but further margin deterioration could limit earnings expansion and temper the stock’s rally.

Analyst Upgrades and Downgrades

AVAH has been the topic of several recent research reports. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. BMO Capital Markets raised their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday. Raymond James Financial restated a “strong-buy” rating and set a $15.00 price target on shares of Aveanna Healthcare in a research note on Friday. Barclays lifted their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Finally, Truist Financial upped their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $11.44.

Insider Transactions at Aveanna Healthcare

In related news, major shareholder Paul R. Vigano sold 7,000,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the completion of the sale, the insider directly owned 252,899 shares in the company, valued at $1,578,089.76. This trade represents a 96.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 31,305,664 shares of company stock worth $215,555,910. 5.30% of the stock is owned by insiders.

Institutional Trading of Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of AVAH. Vanguard Group Inc. lifted its stake in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Aveanna Healthcare by 49.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock worth $8,593,000 after buying an additional 441,707 shares during the last quarter. Segall Bryant & Hamill LLC increased its holdings in shares of Aveanna Healthcare by 425.8% during the first quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after buying an additional 132,779 shares in the last quarter. Weiss Asset Management LP bought a new position in shares of Aveanna Healthcare in the 1st quarter valued at $732,000. Finally, Smith Group Asset Management LLC lifted its stake in shares of Aveanna Healthcare by 34.3% in the 1st quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company’s stock valued at $1,698,000 after acquiring an additional 67,393 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Stock Performance

The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The company has a market cap of $2.59 billion, a price-to-earnings ratio of 10.12, a P/E/G ratio of 0.90 and a beta of 1.90. The company has a fifty day moving average of $8.86 and a two-hundred day moving average of $7.73.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.